Aino Health AB (SE:AINO)
:AINO
Want to see SE:AINO full AI Analyst Report?
Top Page
Aino Health AB
(AINO)
Select Model
Select Model
Rating:44Neutral
Price Target:
kr0.12
▼(-33.33% Downside)
Action:Reiterated
Date:05/16/26
The score is driven primarily by weak financial performance (persistent losses, negative gross profit in 2025, ongoing cash burn, and negative equity). Technicals are only modestly supportive with short-term stabilization but a longer-term downtrend. Valuation is constrained by a negative P/E and no dividend yield data.
Positive Factors
Recurring subscription model
A recurring subscription and service revenue model creates predictable, contractable revenue streams and higher customer lifetime value versus one‑off sales. That structure supports steady top‑line visibility, easier budgeting, and scalable unit economics if the company stabilizes acquisition and retention rates.
Negative Factors
Negative gross profit
Negative gross profit indicates the company’s core offerings currently fail to cover direct costs, undermining scalability and any pathway to sustainable profitability. This structural issue requires either pricing, cost, or product‑mix fixes to restore viable unit economics over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring subscription model
A recurring subscription and service revenue model creates predictable, contractable revenue streams and higher customer lifetime value versus one‑off sales. That structure supports steady top‑line visibility, easier budgeting, and scalable unit economics if the company stabilizes acquisition and retention rates.
Read all positive factors
Aino Health AB (AINO) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr28.03M
Dividend YieldN/A
Average Volume (3M)37.35K
Price to Earnings (P/E)―
Beta (1Y)0.84
Revenue Growth-4.19%
EPS Growth27.20%
CountrySE
Employees19
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.03
Shares Outstanding204,569,100
10 Day Avg. Volume57,458
30 Day Avg. Volume37,353
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)-5.45
Price to Sales (P/S)1.34
P/FCF Ratio-14.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aino Health AB Business Overview & Revenue Model
Company Description
Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Sof...
How the Company Makes Money
Aino Health AB primarily makes money by selling its corporate health and wellbeing offering to employer customers (typically organizations) on a recurring basis, commonly structured as software/service subscriptions or contracted service fees tied...
Aino Health AB Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
22
Negative
Cash Flow
24
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.56M | 26.11M | 23.94M | 23.92M | 19.91M | 23.04M |
| Gross Profit | 25.12M | -5.24M | 21.51M | 3.80M | 17.77M | 21.56M |
| EBITDA | -2.36M | -2.33M | -6.21M | -7.53M | -12.26M | -12.09M |
| Net Income | -6.10M | -6.11M | -9.91M | -10.66M | -14.96M | -15.22M |
Balance Sheet | ||||||
| Total Assets | 7.43M | 9.70M | 9.86M | 13.51M | 17.33M | 19.02M |
| Cash, Cash Equivalents and Short-Term Investments | 834.00K | 5.81M | 741.00K | 1.44M | 2.16M | 453.00K |
| Total Debt | 836.00K | 8.32M | 0.00 | 164.00K | 659.00K | 1.06M |
| Total Liabilities | 8.96M | 16.12M | 10.32M | 14.37M | 19.57M | 16.44M |
| Stockholders Equity | -1.53M | -6.42M | -458.00K | -851.00K | -2.23M | 2.58M |
Cash Flow | ||||||
| Free Cash Flow | -4.01M | -2.41M | -4.55M | -6.26M | -12.87M | -8.11M |
| Operating Cash Flow | -4.01M | -2.41M | -4.55M | -6.26M | -12.87M | -8.11M |
| Investing Cash Flow | -124.00K | 0.00 | 0.00 | 0.00 | 1.32M | 0.00 |
| Financing Cash Flow | 4.78M | 7.62M | 3.82M | 5.57M | 13.19M | -450.00K |
Aino Health AB Technical Analysis
Neutral
0.18
Price Trends
0.14
Positive
0.15
Negative
0.18
Negative
Market Momentum
>-0.01
Positive
49.89
Neutral
24.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AINO, the sentiment is Neutral. The current price of 0.18 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.14, and above the 200-day MA of 0.18, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 49.89 is Neutral, neither overbought nor oversold. The STOCH value of 24.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:AINO.
Aino Health AB Peers Comparison
UnderperformOutperform
Sector (51)
SE:AINO
Aino Health AB
0.14
-0.21
-61.08%
DE:2QE
2cureX AB
0.16
-0.26
-62.68%
DE:4K4
Stayble Therapeutics AB
0.02
-0.02
-42.50%
DE:PGO0
Prostatype Genomics AB
0.03
-0.05
-59.49%
DE:3KT
Kontigo Care AB
0.08
-0.08
-52.20%
DE:COJ0
CombiGene AB
0.16
0.07
83.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.